Publications

RECENT:


  • Tshweu, L. L., Shemis, M.A., Abdelghany, A., Gouda, A., Pilcher, L.A., Sibuyi, N.R.S., Meyer, M., Dube, A., Balogun, M.O. (2020) "Synthesis, physicochemical characterization, toxicity and efficacy of a PEG conjugate and a hybrid PEG conjugate nanoparticle formulation of the antibiotic moxifloxacin." RSC Advances 10(34): 19770-19780.


  • Lerata, M.S., D’Souza, S., Sibuyi, N.R.S., Dube, A., Meyer, M., Samaai, T., Antunes, E.M., Beukes, D.R (2020) "Encapsulation of Variabilin in Stearic Acid Solid Lipid Nanoparticles Enhances Its Anticancer Activity in Vitro." Molecules 25(4), 830.


  • Ndumiso, M., Buchtová, N., Husselmann, L., Mohamed, G., Klein, A., Aucamp, M., Canevet, D., D’Souza, S., Maphasa, R.E., Boury, F and A. Dube (2020) "Comparative whole corona fingerprinting and protein adsorption thermodynamics of PLGA and PCL nanoparticles in human serum." Colloids and Surfaces B: Biointerfaces 188, 110816.


  • Zhou, D.T., Maponga, C.C., Madhombiro, M., Dube, A., Mano, R., Nyamhunga, A., Machingura, I., Manasa, J., Hakim, J.Z., Chirenje, M., Mudzviti, T., Nhachi, C., Ma, Q., Di Francesco, R., Masanganise, R., Morse, G.D. (2019) "Mentored postdoctoral training in Zimbabwe: A report on a successful collaborative effort". Journal of Public Health in Africa 10:1081


  • Samkange, T., S. D'Souza, K. Obikeze and A. Dube (2019) "Influence of PEGylation on PLGA nanoparticle properties, hydrophobic drug release and interactions with human serum albumin." Journal of Pharmacy and Pharmacology 71: 1497-1507.


  • Sousa, C., L. F. Gouveia, B. Kreutzer, B. Silva-Lima, R. E. Maphasa, A. Dube and M. Videira (2019). "Polymeric Micellar Formulation Enhances Antimicrobial and Anticancer Properties of Salinomycin." Pharmaceutical Research 36(6): 83.


  • Sibuyi, N. R. S., Moabelo, K. L., Meyer, M., Onani, M. O., Dube, A and Madiehe, A. M. (2019). "Nanotechnology advances towards development of targeted-treatment for obesity". Journal of Nanobiotechnology, 17(1), 1-21.


  • Omarch, G., Kippie, Y., Mentor, S., Ebrahim, N., Fisher, D., Murilla, G., Swai, H and Dube, A (2019). "Comparative in vitro transportation of pentamidine across the blood-brain barrier using polycaprolactone nanoparticles and phosphatidylcholine liposomes." Artificial Cells, Nanomedicine, and Biotechnology 47(1): 1428-1436.


  • Dube, A. (2019). "Nanomedicines for Infectious Diseases." Pharmaceutical Research 36(4): 63.


  • Ward, K., Suleiman, R., Kippie, Y and Dube, A (2019). "A post-market quality assessment of first-line, fixed-dose combination antiretrovirals in South Africa".


  • Bekale, R. B., Du Plessis, S.-M., Hsu, N.-J., Sharma, J.R., Sampson, S.L., Jacobs, M., Meyer, M., Morse, G.D and Dube, A (2018). "Mycobacterium Tuberculosis and Interactions with the Host Immune System: Opportunities for Nanoparticle Based Immunotherapeutics and Vaccines." Pharmaceutical Research 36(1): 8.


  • Tukulula, M., L. Gouveia, P. Paixao, R. Hayeshi, B. Naicker and A. Dube (2018). "Functionalization of PLGA Nanoparticles with 1,3-β-glucan Enhances the Intracellular Pharmacokinetics of Rifampicin in Macrophages." Pharmaceutical Research 35(6): 111.


  • Manyarara, T. E., S. Khoza, A. Dube and C. C. Maponga (2018). "Formulation and characterization of a paediatric nanoemulsion dosage form with modified oral drug delivery system for improved dissolution rate of nevirapine." MRS Advances: 1-17.


  • Dube, A. and N. Ebrahim (2017). The nanomedicine landscape of South Africa. Nanotechnology Reviews. 6: 339.


  • Dube, A. and J. L. Reynolds (2016). "Modulation of Innate Immune Responses Using Nanoparticles for Infectious Disease Therapy." Current Bionanotechnology 2(1): 60-65.


  • Tukulula, M., R. Hayeshi, P. Fonteh, D. Meyer, A. Ndamase, M. T. Madziva, V. Khumalo, P. Lubuschagne, B. Naicker, H. Swai and A. Dube (2015). "Curdlan-Conjugated PLGA Nanoparticles Possess Macrophage Stimulant Activity and Drug Delivery Capabilities." Pharmaceutical Research 32(8): 2713-2726.


  • Melariri, P., L. Kalombo, P. Nkuna, A. Dube, R. Hayeshi, B. Ogutu, L. Gibhard, C. deKock, P. Smith, L. Wiesner and H. Swai (2015). "Oral lipid-based nanoformulation of tafenoquine enhanced bioavailability and blood stage antimalarial efficacy and led to a reduction in human red blood cell loss in mice." International Journal of Nanomedicine 10: 1493-1503.


  • Kutscher, H. L., F. Makita-Chingombe, S. DiTursi, A. Singh, A. Dube, C. C. Maponga, G. D. Morse and J. L. Reynolds (2015). "Macrophage Targeted Nanoparticles for Antiretroviral (ARV) Delivery." Journal of personalized nanomedicine 1(2): 40-48.


  • Chang, E. H., J. B. Harford, M. A. W. Eaton, P. M. Boisseau, A. Dube, R. Hayeshi, H. Swai and D. S. Lee (2015). "Nanomedicine: Past, present and future – A global perspective." Biochemical and Biophysical Research Communications 468(3): 511-517.


  • Dube, A., J. L. Reynolds, W.-C. Law, C. C. Maponga, P. N. Prasad and G. D. Morse (2014). "Multimodal nanoparticles that provide immunomodulation and intracellular drug delivery for infectious diseases." Nanomedicine: Nanotechnology, Biology and Medicine 10(4): 831-838.


  • Dube, A., Y. Lemmer, R. Hayeshi, M. Balogun, P. Labuschagne, H. Swai and L. Kalombo (2013). "State of the art and future directions in nanomedicine for tuberculosis." Expert Opinion on Drug Delivery 10(12): 1725-1734.


  • Dube, A., J. A. Nicolazzo and I. Larson (2010). "Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (−)-epigallocatechin gallate." European Journal of Pharmaceutical Sciences 41(2): 219-225.


  • Dube, A., K. Ng, J. A. Nicolazzo and I. Larson (2010). "Effective use of reducing agents and nanoparticle encapsulation in stabilizing catechins in alkaline solution." Food Chemistry 122(3): 662-667.